MacroGenics, Inc. - Common Stock (MGNX)
1.7800
+0.1400 (8.54%)
NASDAQ · Last Trade: Jun 10th, 6:27 PM EDT
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 10, 2025
Via Benzinga · June 10, 2025
Via Benzinga · March 24, 2025

Via Benzinga · November 7, 2024
MGNX earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 20, 2025

Via Benzinga · September 18, 2024

Via Benzinga · August 15, 2024

MGNX earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 5, 2024

Via Benzinga · November 6, 2024

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference.
Via Benzinga · July 31, 2024

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.
Via InvestorPlace · July 31, 2024

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.
Via InvestorPlace · July 31, 2024

Via Benzinga · July 31, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!
Via InvestorPlace · July 31, 2024

Via Benzinga · July 31, 2024

Via Benzinga · July 26, 2024

Via Benzinga · June 3, 2024

Investors should take a close look at these biotech stocks as they position themselves to provide high returns.
Via InvestorPlace · May 25, 2024